BeStock  
Stocks › Biotechnology › ATTO

Attovia Therapeutics ATTO

US equityMarket cap rank #3483Biotechnology
$15.72 −$0.70 (-4.26%)
Market open · Oct 8, 12:30 pm ET · After hours $16.42 0.00%
Open$16.27
Prev close$16.42
Day range$15.48 – $16.38
Volume143.3K
Market cap$717.64M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-10.6x
CheapRich

Near the top of its 5-year range · 90th percentile, 5-year average -12.2x

Price / book-5.2x
CheapRich

Near the top of its 5-year range · 90th percentile, 5-year average -6.1x

Price / sales416.4x
CheapRich

Near the bottom of its 5-year range · 12th percentile, 5-year average 528.5x

#5026 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-18x-12x-5x1xJul '26Sep '26Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$26.72
Price vs. fair value-41.2%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -5.15 – -6.11 90% (pricier than usual) –
PE -10.65 -7.52 -12.23 90% (pricier than usual) –
PS 416.44 – 528.52 12% (cheaper than usual) #5026 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$26.72
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on ATTO.

Leave a comment

Scroll to Top